Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing somatropin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Somatropin (substance) |
Inferred relationship |
Some |
1 |
Somatropin 12 mg powder for solution for injection cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
Somatropin [2] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
Somatropin 5.8mg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
somatropin 13,8 mg pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
somatropin 0,2 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
somatropin 0,4 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
Somatropin 0.6mg injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
somatropin 0,8 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
somatropin 1,0 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
somatropin 1,2 mg pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
somatropin 1,4 mg pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
somatropin 1,6 mg pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
somatropin 1,8 mg pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
somatropin 2 mg pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
Somatropin 5.0mg/1.5mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
Somatropin 10.0mg/1.5mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
Somatropin 15mg/1.5mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
Somatropin 5mg/vial injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
Somatropin 5mg injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
Somatropin 10mg injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
somatropin 10 mg/2 ml opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
somatropin 10 mg hætteglas opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
Somatropin 1.5mg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
somatropin 0,44 mg/enhed pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
somatropin 0,6 mg/enhed pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
somatropin 0,8 mg/enhed pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
somatropin 1,2 mg/0,25 ml pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
somatropin 1,4 mg/0,25 ml pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
somatropin 1,6 mg/0,25 ml pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
somatropin 1,8 mg/0,25 ml pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
somatropin 2,0 mg/0,25 ml pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
Somatropin 12mg injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
Somatropin 6mg injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
somatropin (enzymatisk konverteret precursor) |
Is a |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
somatropin (rekombinant, Escherichia coli) |
Is a |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
somatropin (rekombinant, museceller) |
Is a |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
somatropin 12 mg pulver til injektionsvæske, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
somatropin 0,6 mg pulver til injektionsvæske, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
somatropin 15 mg/1,5 ml injektionsvæske, opløsning, cylinderampul a 1,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
somatropin 5,0 mg/1,5 ml injektionsvæske, opløsning, cylinderampul a 1,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
somatropin 5 mg pulver til injektionsvæske, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
somatropin 10 mg pulver til injektionsvæske, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
somatropin 6 mg pulver til injektionsvæske, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
somatropin 10,0 mg/1,5 ml injektionsvæske, opløsning, cylinderampul a 1,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
somatropin 4 mg pulver til injektionsvæske, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
somatropin 8,8 mg pulver til injektionsvæske, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
somatropin 13,5 mg/3 ml injektionsvæske, opløsning, hætteglas a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
somatropin 18 mg/3 ml injektionsvæske, opløsning, hætteglas a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
somatropin 22,5 mg/3 ml injektionsvæske, opløsning, hætteglas a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
somatropin (rbe) 5 mg (15 IE)/ml, injektionsvæske, opløsning, cylinderampul a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
humant væksthormon |
Is a |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
Somatrophic hormone adverse reaction |
Causative agent |
True |
Somatropin (substance) |
Inferred relationship |
Some |
1 |
Allergy to somatropin hormone (finding) |
Causative agent |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
Somatrem |
Is a |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
Sermorelin (substance) |
Is a |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
Somatotropin challenge tests |
Component |
False |
Somatropin (substance) |
Inferred relationship |
Some |
1 |
45 minute serum growth hormone measurement (procedure) |
Component |
False |
Somatropin (substance) |
Inferred relationship |
Some |
2 |
Growth hormone measurement |
Component |
False |
Somatropin (substance) |
Inferred relationship |
Some |
1 |
Serum growth hormone measurement |
Component |
False |
Somatropin (substance) |
Inferred relationship |
Some |
2 |
Plasma growth hormone measurement |
Component |
False |
Somatropin (substance) |
Inferred relationship |
Some |
2 |
90 minute plasma GH measurement |
Component |
False |
Somatropin (substance) |
Inferred relationship |
Some |
2 |
60 minute plasma GH measurement |
Component |
False |
Somatropin (substance) |
Inferred relationship |
Some |
2 |
30 minute plasma GH measurement |
Component |
False |
Somatropin (substance) |
Inferred relationship |
Some |
2 |
120 minute plasma GH measurement |
Component |
False |
Somatropin (substance) |
Inferred relationship |
Some |
2 |
30 minute serum GH measurement |
Component |
False |
Somatropin (substance) |
Inferred relationship |
Some |
2 |
60 minute serum GH measurement |
Component |
False |
Somatropin (substance) |
Inferred relationship |
Some |
2 |
90 minute serum GH measurement |
Component |
False |
Somatropin (substance) |
Inferred relationship |
Some |
2 |
180 minute plasma GH measurement |
Component |
False |
Somatropin (substance) |
Inferred relationship |
Some |
2 |
210 minute plasma GH measurement |
Component |
False |
Somatropin (substance) |
Inferred relationship |
Some |
2 |
210 minute serum GH measurement |
Component |
False |
Somatropin (substance) |
Inferred relationship |
Some |
2 |
240 minute serum GH measurement |
Component |
False |
Somatropin (substance) |
Inferred relationship |
Some |
2 |
150 minute plasma GH measurement |
Component |
False |
Somatropin (substance) |
Inferred relationship |
Some |
2 |
240 minute plasma GH measurement |
Component |
False |
Somatropin (substance) |
Inferred relationship |
Some |
2 |
120 minute serum GH measurement |
Component |
False |
Somatropin (substance) |
Inferred relationship |
Some |
2 |
150 minute serum GH measurement |
Component |
False |
Somatropin (substance) |
Inferred relationship |
Some |
2 |
180 minute serum GH measurement |
Component |
False |
Somatropin (substance) |
Inferred relationship |
Some |
2 |
Urine growth hormone level (procedure) |
Component |
False |
Somatropin (substance) |
Inferred relationship |
Some |
2 |
somatropin 1,5 mg pulver til injektionsvæske, opløsning, hætteglas + diluent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
somatropin 5,8 mg pulver til injektionsvæske, opløsning, hætteglas + diluent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
forgiftning med somatotropin |
Causative agent |
False |
Somatropin (substance) |
Inferred relationship |
Some |
1 |
forgiftning med somatotropin, uvist med hvilken hensigt |
Causative agent |
False |
Somatropin (substance) |
Inferred relationship |
Some |
1 |
accidentel forgiftning med somatropin |
Causative agent |
False |
Somatropin (substance) |
Inferred relationship |
Some |
1 |
tilsigtet forgiftning med somatotropin |
Causative agent |
False |
Somatropin (substance) |
Inferred relationship |
Some |
1 |
Somatropin 5mg/mL injection solution 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
Glucagon stimulation test |
Component |
False |
Somatropin (substance) |
Inferred relationship |
Some |
1 |
Allergy to somatropin hormone (finding) |
Causative agent |
True |
Somatropin (substance) |
Inferred relationship |
Some |
1 |
Somatropin 1.5mg powder for conventional release solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
Somatropin 5.8mg powder for conventional release solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
Somatropin-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Somatropin (substance) |
Inferred relationship |
Some |
1 |
Sermorelin acetate (substance) |
Is a |
False |
Somatropin (substance) |
Inferred relationship |
Some |
|
Product containing only somatropin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Somatropin (substance) |
Inferred relationship |
Some |
1 |
Somatropin only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Somatropin (substance) |
Inferred relationship |
Some |
1 |
Somatropin 12 mg powder for solution for injection cartridge |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Somatropin (substance) |
Inferred relationship |
Some |
1 |
Somatropin 12 mg powder for solution for injection cartridge |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Somatropin (substance) |
Inferred relationship |
Some |
1 |
Somatropin 10 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Somatropin (substance) |
Inferred relationship |
Some |
1 |
Somatropin 10 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Somatropin (substance) |
Inferred relationship |
Some |
1 |
Somatropin 4 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Somatropin (substance) |
Inferred relationship |
Some |
1 |
Somatropin 4 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Somatropin (substance) |
Inferred relationship |
Some |
1 |
Poisoning caused by somatropin (disorder) |
Causative agent |
True |
Somatropin (substance) |
Inferred relationship |
Some |
1 |
Accidental somatropin poisoning |
Causative agent |
True |
Somatropin (substance) |
Inferred relationship |
Some |
1 |